Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuying Wan

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
JAMA Surgery|November 19, 2015
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan CriteriaZhengqing Lei, Jun Li, Dong Wu, et al.
World Journal of Surgical Oncology|February 11, 2023
Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinomaJian Liu, Hao Shen, Shengyu Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomyYizhou Wang, Jun Li, Yong Xia, et al.
Plos One|May 17, 2016
Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular CarcinomaJian Liu, Kui Wang, Zhenlin Yan, et al.
The Oncologist|May 10, 2015
Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk StratificationJun Li, Qing Wang, Zhengqing Lei, et al.
JAMA Surgery|August 4, 2018
Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular CarcinomaZheng Li, Zhengqing Lei, Yong Xia, et al.
Journal of Hepatology|November 21, 2017
Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resectionZhengqing Lei, Yong Xia, Anfeng Si, et al.
Ebiomedicine|May 17, 2018
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition PathwayQifei Zou, Ying Hou, Haibo Wang, et al.
Gastroenterology Report|June 29, 2023
Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risksPinghua Yang, Fei Teng, Shilei Bai, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2020
Adjuvant <sup>131</sup>I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trialJun Li, Jingliang Xing, Yefa Yang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
JAMA Surgery|November 19, 2015
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan CriteriaZhengqing Lei, Jun Li, Dong Wu, et al.
World Journal of Surgical Oncology|February 11, 2023
Antiviral therapy inhibited HBV-reactivation and improved long-term outcomes in patients who underwent radiofrequency ablation for HBV-related hepatocellular carcinomaJian Liu, Hao Shen, Shengyu Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomyYizhou Wang, Jun Li, Yong Xia, et al.
Plos One|May 17, 2016
Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular CarcinomaJian Liu, Kui Wang, Zhenlin Yan, et al.
The Oncologist|May 10, 2015
Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk StratificationJun Li, Qing Wang, Zhengqing Lei, et al.
JAMA Surgery|August 4, 2018
Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular CarcinomaZheng Li, Zhengqing Lei, Yong Xia, et al.
Journal of Hepatology|November 21, 2017
Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resectionZhengqing Lei, Yong Xia, Anfeng Si, et al.
Ebiomedicine|May 17, 2018
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition PathwayQifei Zou, Ying Hou, Haibo Wang, et al.
Gastroenterology Report|June 29, 2023
Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risksPinghua Yang, Fei Teng, Shilei Bai, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2020
Adjuvant <sup>131</sup>I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trialJun Li, Jingliang Xing, Yefa Yang, et al.
Pageof 4